These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Metabolic studies of glycosphingolipid accumulation in mucopolysaccharidosis IIID. Liour SS; Jones MZ; Suzuki M; Bieberich E; Yu RK Mol Genet Metab; 2001 Mar; 72(3):239-47. PubMed ID: 11243730 [TBL] [Abstract][Full Text] [Related]
6. Enzyme Replacement Therapy for Mucopolysaccharidosis IIID using Recombinant Human α- Wang F; Moen DR; Sauni C; Kan SH; Li S; Le SQ; Lomenick B; Zhang X; Ekins S; Singamsetty S; Wood J; Dickson PI; Chou TF Mol Pharm; 2021 Jan; 18(1):214-227. PubMed ID: 33320673 [TBL] [Abstract][Full Text] [Related]
7. Genomic basis of mucopolysaccharidosis type IIID (MIM 252940) revealed by sequencing of GNS encoding N-acetylglucosamine-6-sulfatase. Mok A; Cao H; Hegele RA Genomics; 2003 Jan; 81(1):1-5. PubMed ID: 12573255 [TBL] [Abstract][Full Text] [Related]
8. Sulfamidase deficiency in a family of Dachshunds: a canine model of mucopolysaccharidosis IIIA (Sanfilippo A). Fischer A; Carmichael KP; Munnell JF; Jhabvala P; Thompson JN; Matalon R; Jezyk PF; Wang P; Giger U Pediatr Res; 1998 Jul; 44(1):74-82. PubMed ID: 9667374 [TBL] [Abstract][Full Text] [Related]
9. Glycosaminoglycans and mucopolysaccharidosis type III. Jakobkiewicz-Banecka J; Gabig-Ciminska M; Kloska A; Malinowska M; Piotrowska E; Banecka-Majkutewicz Z; Banecki B; Wegrzyn A; Wegrzyn G Front Biosci (Landmark Ed); 2016 Jun; 21(7):1393-409. PubMed ID: 27100513 [TBL] [Abstract][Full Text] [Related]
10. Sanfilippo syndrome type D: natural history and identification of 3 novel mutations in the GNS Gene. Jansen AC; Cao H; Kaplan P; Silver K; Leonard G; De Meirleir L; Lissens W; Liebaers I; Veilleux M; Andermann F; Hegele RA; Andermann E Arch Neurol; 2007 Nov; 64(11):1629-34. PubMed ID: 17998446 [TBL] [Abstract][Full Text] [Related]
11. The ultrastructure of skin from a patient with mucopolysaccharidosis IIID. Alroy J; Jones MZ; Rutledge JC; Taylor JW; Toone J; Applegarth D; Hopwood JJ Acta Neuropathol; 1997 Feb; 93(2):210-3. PubMed ID: 9039471 [TBL] [Abstract][Full Text] [Related]
12. Accumulation of intracellular amyloid-beta peptide (A beta 1-40) in mucopolysaccharidosis brains. Ginsberg SD; Galvin JE; Lee VM; Rorke LB; Dickson DW; Wolfe JH; Jones MZ; Trojanowski JQ J Neuropathol Exp Neurol; 1999 Aug; 58(8):815-24. PubMed ID: 10446806 [TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of brain pathology in heparan sulphate storing mucopolysaccharidoses. Derrick-Roberts A; Kaidonis X; Jackson MR; Liaw WC; Ding X; Ong C; Ranieri E; Sharp P; Fletcher J; Byers S Mol Genet Metab; 2020; 131(1-2):197-205. PubMed ID: 32739280 [TBL] [Abstract][Full Text] [Related]
14. Lysosomal storage of heparan sulfate causes mitochondrial defects, altered autophagy, and neuronal death in the mouse model of mucopolysaccharidosis III type C. Pshezhetsky AV Autophagy; 2016 Jun; 12(6):1059-60. PubMed ID: 25998837 [TBL] [Abstract][Full Text] [Related]
15. A mouse model for mucopolysaccharidosis type III A (Sanfilippo syndrome). Bhaumik M; Muller VJ; Rozaklis T; Johnson L; Dobrenis K; Bhattacharyya R; Wurzelmann S; Finamore P; Hopwood JJ; Walkley SU; Stanley P Glycobiology; 1999 Dec; 9(12):1389-96. PubMed ID: 10561464 [TBL] [Abstract][Full Text] [Related]